Literature DB >> 7693985

Characterization of human prostate cancer, benign prostatic hyperplasia and normal prostate by in vitro 1H and 31P magnetic resonance spectroscopy.

E B Cornel1, G A Smits, G O Oosterhof, H F Karthaus, F M Deburyne, J A Schalken, A Heerschap.   

Abstract

In vitro 1H and 31P magnetic resonance spectra were acquired from perchloric acid extracts of human prostate tissue obtained by transurethral resection. This included tissue of patients with benign prostatic hyperplasia and prostatic adenocarcinoma; one tissue sample was obtained from a patient without any sign of BPH or malignancy. Major resonances in the magnetic resonance spectra were assigned to prostate compounds and were quantified. The citrate/lactate, citrate/total choline, phosphocholine/total creatinine, choline/total creatine, alanine/total creatine, phosphoethanolamine/total phosphate, phosphocholine/total phosphate and glycerophosphoethanolamine/total phosphate ratios were statistically different for the prostate cancer samples as compared with the BPH specimens. These observations may contribute to the understanding of in vivo magnetic resonance spectra of the prostate and indicate that magnetic resonance spectroscopy can aid in the diagnosis of prostate malignancy.

Entities:  

Mesh:

Year:  1993        PMID: 7693985     DOI: 10.1016/s0022-5347(17)35957-8

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  24 in total

Review 1.  Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer.

Authors:  J Kurhanewicz; D B Vigneron; S J Nelson
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

2.  Recent Advances in Metabolic Profiling And Imaging of Prostate Cancer.

Authors:  Roopa Thapar; Mark A Titus
Journal:  Curr Metabolomics       Date:  2014-04

3.  Discrimination of prostate carcinoma from benign prostate tissue fragments in vitro by estimating the gross biochemical alterations through Raman spectroscopy.

Authors:  Landulfo Silveira; Kátia Ramos M Leite; Fabricio Luiz Silveira; Miguel Srougi; Marcos Tadeu T Pacheco; Renato Amaro Zângaro; Carlos Augusto Pasqualucci
Journal:  Lasers Med Sci       Date:  2014-03-12       Impact factor: 3.161

4.  Proton MR spectroscopy of prostatic tissue focused on the detection of spermine, a possible biomarker of malignant behavior in prostate cancer.

Authors:  M van der Graaf; R G Schipper; G O Oosterhof; J A Schalken; A A Verhofstad; A Heerschap
Journal:  MAGMA       Date:  2000-07       Impact factor: 2.310

5.  Lactate MRSI and DCE MRI as surrogate markers of prostate tumor aggressiveness.

Authors:  J Yaligar; S B Thakur; L Bokacheva; S Carlin; H T Thaler; A Rizwan; M E Lupu; Y Wang; C C Matei; K L Zakian; J A Koutcher
Journal:  NMR Biomed       Date:  2011-05-25       Impact factor: 4.044

6.  Is higher lactate an indicator of tumor metastatic risk? A pilot MRS study using hyperpolarized (13)C-pyruvate.

Authors:  He N Xu; Stephen Kadlececk; Harrilla Profka; Jerry D Glickson; Rahim Rizi; Lin Z Li
Journal:  Acad Radiol       Date:  2014-02       Impact factor: 3.173

7.  Metabolomic characterization of human prostate cancer bone metastases reveals increased levels of cholesterol.

Authors:  Elin Thysell; Izabella Surowiec; Emma Hörnberg; Sead Crnalic; Anders Widmark; Annika I Johansson; Pär Stattin; Anders Bergh; Thomas Moritz; Henrik Antti; Pernilla Wikström
Journal:  PLoS One       Date:  2010-12-03       Impact factor: 3.240

8.  Quantification of choline- and ethanolamine-containing metabolites in human prostate tissues using 1H HR-MAS total correlation spectroscopy.

Authors:  Mark G Swanson; Kayvan R Keshari; Z Laura Tabatabai; Jeffry P Simko; Katsuto Shinohara; Peter R Carroll; Andrew S Zektzer; John Kurhanewicz
Journal:  Magn Reson Med       Date:  2008-07       Impact factor: 4.668

9.  Analysis of hyperpolarized dynamic 13C lactate imaging in a transgenic mouse model of prostate cancer.

Authors:  Janine M Lupo; Albert P Chen; Matthew L Zierhut; Robert A Bok; Charles H Cunningham; John Kurhanewicz; Daniel B Vigneron; Sarah J Nelson
Journal:  Magn Reson Imaging       Date:  2009-08-19       Impact factor: 2.546

10.  Methods for metabolic evaluation of prostate cancer cells using proton and (13)C HR-MAS spectroscopy and [3-(13)C] pyruvate as a metabolic substrate.

Authors:  Yakir S Levin; Mark J Albers; Thomas N Butler; Daniel Spielman; Donna M Peehl; John Kurhanewicz
Journal:  Magn Reson Med       Date:  2009-11       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.